Ascend Laboratories supplier risk profile Q1-2026: India-focused pharma importer, B-grade risk score.
Ascend Laboratories imported 138 shipments in Q1 2026 across five suppliers, all sourced from India. The company concentrated its entire import volume in a single country, with India accounting for 100% of shipments. Alkem Laboratories dominated the supplier base with 114 shipments, followed by Inventia Healthcare with 11 shipments. The primary product category falls under HS Chapter 30 (pharmaceutical products).
Trigram screen against OFAC SDN, BIS Entity List, UFLPA Entity List, SAM Exclusions, EU FSF, UK HMT, UN SC, and 25+ allied jurisdictions.
Distance-screened against all 380 facilities in the ASPI Xinjiang Data Project. Proximity score: 100 / 100.
The importer registered zero sanctions watchlist hits in Q1 2026. No suppliers in Ascend Laboratories' network showed forced-labor exposure under UFLPA proximity screening.
5 distinct tier-1 suppliers in Q1 2026
| ALKEM LABORATORIES | India | 114 |
| INVENTIA HEALTHCARE | India | 11 |
| GRANULES INDIA | India | 6 |
| HARMAN FINOCHEM | India | 6 |
| PINNACLE LIFE SCIENCE | India | 1 |
Share of Q1 2026 inbound shipments by source country
5 tier-2 + 5 tier-3 nodes mapped - sign up to see them.
Free Tarifflo account unlocks the complete tier 1 / 2 / 3 supplier graph, daily refresh, alerts, and sanctions + UFLPA monitoring on every shipment.